Synlogic, Inc. (LON:0A8U)
1.757
0.00 (0.00%)
At close: Oct 27, 2025
Synlogic Revenue
In the year 2024, Synlogic had annual revenue of $8.00K USD, down -99.76%.
Revenue
$8.00K
Revenue Growth
-99.76%
P/S Ratio
n/a
Revenue / Employee
$8.00K
Employees
1
Market Cap
15.64M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.00K | -3.36M | -99.76% |
| Dec 31, 2023 | 3.37M | 2.19M | 185.68% |
| Dec 31, 2022 | 1.18M | -574.00K | -32.73% |
| Dec 31, 2021 | 1.75M | 1.21M | 221.83% |
| Dec 31, 2020 | 545.00K | -1.68M | -75.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |
Synlogic News
- 2 months ago - Synlogic files $150M mixed securities shelf - Seeking Alpha
- 1 year ago - Synlogic Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Adopts Limited Duration Stockholders Rights Plan - GlobeNewsWire
- 1 year ago - Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update - GlobeNewsWire
- 1 year ago - Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria - GlobeNewsWire